Zobrazeno 1 - 10
of 44
pro vyhledávání: '"İlhan Yıldırım"'
Autor:
Tezcan Kaya, Sena Boncuk Ulaş, Ahmet Nalbant, İlhan Yıldırım, Kubilay İşsever, Cengiz Karacaer, Cahit Bilgin, Aslı Vatan, Türkan Acar, Bilgehan Atılgan Acar, Yeşim Güzey Aras, Mehmet Köroğlu
Publikováno v:
Brain and Behavior, Vol 14, Iss 9, Pp n/a-n/a (2024)
Abstract Background and aims The C‐reactive protein to albumin ratio (CAR) is a novel parameter that has been reported as a significant prognostic marker in some diseases. The purpose of the present research was to investigate the predictive value
Externí odkaz:
https://doaj.org/article/c617261f94714ac583e47a16ad1bfa7a
Autor:
Deniz Çekiç, Ahmed Cihad Genç, Kubilay İşsever, Sümeyye Çekiç, İlhan Yıldırım, Ahmet Nalbant, Ahmed Bilal Genç, Selcuk Yaylacı, Ali Tamer, Hamad Dheir
Publikováno v:
Sakarya Tıp Dergisi, Vol 12, Iss 3, Pp 416-421 (2022)
Amaç: 2019 aralık ayında başlayan Sars-Cov-2 adı verilen koronavirüs ailesine ait olan koronavirüs nedeniyle mart 2020 ayında tüm dünyada pandemi ilan edildi ve virüsün yol açtığı hastalık Covid-19 olarak anılmaya başlandı. Yakla
Externí odkaz:
https://doaj.org/article/fff57818f51348d88856d8ccca1e5225
Autor:
Deniz Çekiç, Kubilay Işsever, Selçuk Yaylacı, Didar Şenocak, Sümeyye Çekiç, Ilhan Yıldırım, Mehmet Halil Öztürk, Oğuz Karabay
Publikováno v:
Ķazaķstannyṇ Klinikalyķ Medicinasy, Vol 18, Iss 3, Pp 58-61 (2021)
Introduction: SARS-Corona Virus-2 (SARS-CoV-2/COVID-19) is a novel member of coronaviridae family. This new disease first appeared in China in December 2019, and can cause severe respiratory failure in advanced cases. COVID-19 was announced as a pand
Externí odkaz:
https://doaj.org/article/fe44263e8a354b0ca854a7d100e24da3
Autor:
İlhan Yıldırım
Publikováno v:
Sakarya Tıp Dergisi, Vol 9, Iss 4, Pp 698-701 (2019)
Anti-TNFa ajanları çeşitli otoimmün ve inflamtuvar barsak hastalıklarında alternatif tedavi olarak üretilmiştir. Klinik etkinliklerine rağmen anti-TNFa ajanları SSS’inde demyelinizasyon yaptığına dair çeşitli nörolojik yan etkiler y
Externí odkaz:
https://doaj.org/article/b110a435216944fc9e1e313699b47eaa
Autor:
Zeynep Ergenc, Hasan Ergenc, İlhan Yıldırım, Ahmet Öztürk, Mustafa Usanmaz, Cengiz Karacaer, Serkan Günay, Gülsüm Kaya
Publikováno v:
Medical Science and Discovery. 10:1-7
Objective: This study aims to examine the relationship between serum vitamin D levels and hematological parameters, and body mass index. Material and Methods: It was carried out in the internal medicine outpatient clinic of Ayancık State Hospital be
Publikováno v:
Istanbul Management Journal. :61-90
Accountability and performance evaluation are needed for effective and efficient use of a country’s scarce public resources. In this study, detection procedures conducted in Treasury (or State) property of the General Directorate of National Proper
Autor:
Selcuk Yaylaci, Ahmed Bilal Genc, İlhan Yıldırım, Kubilay İşsever, Ahmed Cihad Genc, Deniz Çekiç
Publikováno v:
Journal of the College of Physicians and Surgeons Pakistan. 31:S99-S103
OBJECTIVE: To analyse whether prealbumin could be a new biomarker for predicting mortality in severe COVID-19 patients. STUDY DESIGN: An observation study. PLACE AND DURATION OF STUDY: Intensive care units (ICU) of Sakarya University Training and Res
Autor:
Sümeyye Çekiç, Deniz Çekiç, İlhan Yıldırım, Selcuk Yaylaci, Mehmet Halil Öztürk, Kubilay İşsever, Oguz Karabay, Didar Şenocak
Publikováno v:
Ķazaķstannyṇ Klinikalyķ Medicinasy, Vol 18, Iss 3, Pp 58-61 (2021)
Introduction: SARS-Corona Virus-2 (SARS-CoV-2/COVID-19) is a novel member of coronaviridae family. This new disease first appeared in China in December 2019, and can cause severe respiratory failure in advanced cases. COVID-19 was announced as a pand
Autor:
Erdem Çokluk, İlhan Yıldırım, Ertugrul Guclu, Ahmet Nalbant, Havva Kocayigit, Tezcan Kaya, Selcuk Yaylaci, Mehmet Koroglu, Mehmet Ramazan Şekeroğlu
Publikováno v:
Irish Journal of Medical Science
Background Some biomarkers have been reported to be related to the prognosis of the coronavirus disease 2019 (COVID-19). There are sparse data regarding the prognostic value of serum calprotectin in COVID-19 patients. Aims This study aimed to investi
Autor:
Ceyhun Varim, Fatıma Betül Tuncer, Ilhan Hacibekiroglu, İlhan Yıldırım, Hasret Cengiz, Hande Toptan, Oguz Karabay, Taner Demirci, Erdem Çokluk
Publikováno v:
Wiener Klinische Wochenschrift
Wiener klinische Wochenschrift
Wiener klinische Wochenschrift
Summary Background Coronavirus disease 2019 (COVID-19) is an acute inflammatory respiratory disease. Osteopontin (OPN) is a glycoprotein expressed in various cell types, such as bone, immune, smooth muscle, epithelial and endothelial cells. It also a